JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$1.09B |
| 2 |
Broadcom
AVGO
|
+$1.03B |
| 3 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$970M |
| 4 |
Vanguard Short-Term Bond ETF
BSV
|
+$877M |
| 5 |
Verizon
VZ
|
+$875M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.58B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$1.37B |
| 3 |
TWX
Time Warner Inc
TWX
|
+$764M |
| 4 |
IBM
IBM
|
+$737M |
| 5 |
Philip Morris
PM
|
+$640M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.15% |
| 2 | Financials | 14% |
| 3 | Technology | 12.71% |
| 4 | Healthcare | 9.7% |
| 5 | Consumer Discretionary | 8.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
ETP
2776
PUT
DELISTED
Energy Transfer Partners, L.P.
ETP
| $3.81M | ﹤0.01% |
200,000
| – | – |
2017 Q4
2 quarters
|
|
|
FPRX
2777
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $3.81M | ﹤0.01% |
240,789
-112,218
| -32% | -$1.96M |
2015 Q4
10 quarters
|
|
|
TSRO
2778
DELISTED
TESARO, Inc.
TSRO
| $3.8M | ﹤0.01% |
85,449
-7,079
| -8% | -$344K |
2015 Q2
12 quarters
|
|
2779
PUT
DexCom
DXCM
$32.2B
| $3.8M | ﹤0.01% |
+160,000
| New | +$3.39M |
2018 Q2
0 quarters
|
|
2780
CALL
Crown Castle
CCI
$28.3B
| $3.79M | ﹤0.01% |
35,200
+18,000
| +105% | +$1.87M |
2017 Q2
4 quarters
|
|
2781
Dycom Industries
DY
$8.26B
| $3.79M | ﹤0.01% |
40,128
-74,542
| -65% | -$7.63M |
2015 Q1
13 quarters
|
|
|
LJPC
2782
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $3.79M | ﹤0.01% |
130,029
-7,115
| -5% | -$220K |
2017 Q4
2 quarters
|
|
2783
ESCO Technologies
ESE
$7.12B
| $3.79M | ﹤0.01% |
65,724
+12,119
| +23% | +$696K |
2016 Q2
8 quarters
|
|
2784
Atkore
ATKR
$3.2B
| $3.79M | ﹤0.01% |
182,402
-27,817
| -13% | -$564K |
2017 Q1
5 quarters
|
|
|
APTX
2785
DELISTED
Aptinyx Inc. Common Stock
APTX
| $3.79M | ﹤0.01% |
+156,700
| New | +$3.35M |
2018 Q2
0 quarters
|
|
2786
PUT
Globus Medical
GMED
$10.2B
| $3.79M | ﹤0.01% |
+75,000
| New | +$3.91M |
2018 Q2
0 quarters
|
|
|
MDR
2787
CALL
DELISTED
McDermott International
MDR
| $3.79M | ﹤0.01% |
192,644
+139,311
| +261% | +$2.83M |
2017 Q4
2 quarters
|
|
|
AEGN
2788
DELISTED
Aegion Corp
AEGN
| $3.78M | ﹤0.01% |
146,770
-73,236
| -33% | -$1.82M |
2013 Q2
20 quarters
|
|
2789
Hain Celestial
HAIN
$47.2M
| $3.77M | ﹤0.01% |
126,450
+38,142
| +43% | +$1.09M |
2013 Q2
20 quarters
|
|
2790
First Trust Emerging Markets AlphaDEX Fund
FEM
$813M
| $3.77M | ﹤0.01% |
145,677
+1,483
| +1% | +$41.7K |
2016 Q3
7 quarters
|
|
|
CLUB
2791
DELISTED
Town Sports International Holdings, Inc.
CLUB
| $3.77M | ﹤0.01% |
258,910
+151,643
| +141% | +$1.59M |
2017 Q2
4 quarters
|
|
2792
VanEck Junior Gold Miners ETF
GDXJ
$8.39B
| $3.77M | ﹤0.01% |
115,170
-49,568
| -30% | -$1.63M |
2016 Q2
8 quarters
|
|
|
FOLD
2793
CALL
DELISTED
Amicus Therapeutics
FOLD
| $3.75M | ﹤0.01% |
240,000
+150,000
| +167% | +$2.27M |
2017 Q4
2 quarters
|
|
2794
Viavi Solutions
VIAV
$11.6B
| $3.74M | ﹤0.01% |
365,633
+282,110
| +338% | +$2.79M |
2013 Q2
20 quarters
|
|
|
EXPR
2795
DELISTED
Express, Inc.
EXPR
| $3.74M | ﹤0.01% |
20,455
-440
| -2% | -$76.3K |
2013 Q2
20 quarters
|
|
2796
TG Therapeutics
TGTX
$8.31B
| $3.74M | ﹤0.01% |
284,540
-15,697
| -5% | -$216K |
2016 Q4
6 quarters
|
|
2797
Hyster-Yale Materials Handling
HY
$560M
| $3.73M | ﹤0.01% |
58,105
-10,883
| -16% | -$756K |
2013 Q2
20 quarters
|
|
|
VSTO
2798
DELISTED
Vista Outdoor Inc.
VSTO
| $3.73M | ﹤0.01% |
240,712
+74,583
| +45% | +$1.19M |
2015 Q1
13 quarters
|
|
|
OSB
2799
DELISTED
Norbord Inc.
OSB
| $3.72M | ﹤0.01% |
90,494
+28,413
| +46% | +$1.17M |
2016 Q3
7 quarters
|
|
2800
iShares MSCI Malaysia ETF
EWM
$284M
| $3.72M | ﹤0.01% |
119,188
-223,055
| -65% | -$7.59M |
2013 Q2
20 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2018 Portfolio in Review
As of Q2 2018, JP Morgan Chase held 5,918 positions worth $486B, up 4.2% from $467B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q2 2018 filing shows 539 new, 2,430 increased, 2,080 reduced and 346 closed positions. Its largest new stake was Evergy: 3,598,208 shares worth $202M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $2.58B.
By sector, the portfolio is most concentrated in Miscellaneous at 24% of assets, up from 23% a quarter earlier, followed by Financials and Technology.
- JP Morgan Chase's largest Q2 2018 buy was Evergy: 3,598,208 shares worth $202M.
- JP Morgan Chase added most to Salesforce in Q2 2018, an estimated $1.09B increase.
- JP Morgan Chase's biggest Q2 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.58B.
- JP Morgan Chase fully exited Time Warner Inc in Q2 2018, selling an estimated $764M.
- JP Morgan Chase's ten largest holdings make up 17% of its $486B portfolio in Q2 2018.
- JP Morgan Chase opened 539 new positions and closed 346 in Q2 2018.
- JP Morgan Chase's portfolio value rose 4.2% quarter-over-quarter to $486B.
Based on JP Morgan Chase's 13F filing for Q2 2018, filed 14 Aug 2018.